|
|
|
«
123
A
An
B
C
Ci
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
So
T
U
V
W
XYZ
»
«
AA
Acac
Acor
Aden
AEA
AIF
Alch
Alli
Alp
Altu
Ana
»
|
 |
|
|
AAC Capital Partners
Offices: The Netherlands, London, England
& Stockholm, Sweden
AAC Capital Partners is a leading Northern
European mid-market buy-out firm with a
unique regional footprint. Made up of the
former Dutch, Nordic and UK buy-out teams
of ABN AMRO Capital, they lead buy-outs
within the €50 - 500 million deal range
in the consumer, industrial and services
sector. AAC targets opportunities for majority
stakes in profitable, cash-generative companies
headquartered in the Netherlands, Nordic
region and the UK. |
AAVIN
Offices: Cedar Rapids, Iowa
AAVIN is a private equity firm who invest
in high-growth opportunities, management
buyouts and certain recapitalization transactions.
They partner with strong management teams
seeking to build businesses through internal
growth or acquisitions. They invest primarily
in late-stage and expansion-stage financings. |
Abbott Capital
Offices: New York, New York
Abbott Capital was founded in 1986 as an
independent registered investment adviser
and has focused exclusively on private equity—venture
capital, buyouts and special situations—by
making investments in professionally managed
partnerships. Abbott Capital offers a unique
combination of performance, continuity among
senior professionals and alignment of interests
that stems from its history as an independent
manager focused solely on private equity
investments. |
Aberdare Ventures
Offices: San Francisco, California
The Aberdare Ventures team are experienced
venture investors and operators of healthcare
technology companies. Their investment focus
is driven by their years of experience growing
biopharmaceutical product companies and
therapeutic medical device companies. They
have plenty of experience leading early-stage
investments, but they are comfortable co-investing
as well. Aberdare is willing to participate
in financings as small as $1 million, but
also has the capacity to invest $4-7 million
in a company over time. |
|
|
Abingworth Management
Offices: Palo Alto, California; Boston,
Massachusetts & London, England
Abingworth is a long-established venture
capital firm specializing in unquoted and
life science biomedical companies. Abingworth
is active on both sides of the Atlantic
and, in the past fifteen years, has backed
more than 80 developing life science/medical
businesses. The majority of these have gone
on to public offerings or have merged or
been acquired by leading companies in the
industry. Abingworth has funds under management
of over $700 million. |
ABN AMRO Private Equity
Offices: Chicago, Illinois
ABN AMRO Private Equity invests across a
broad spectrum of the communications industry.
The combination of the migration to packet-based
communications networks and The Telecommunications
Act of 1996 have forever changed the landscape
of the communications industry. ABN AMRO
Private Equity believes that increased competition,
new technologies and decreased regulation
will all lead to continued explosive growth
in communications sector. |
ABRY Partners
Offices: Boston, Massachusetts
ABRY Partners is one of the most experienced
and successful media-focused private equity
investment firms in North America. Since
1989, ABRY has completed over $7.0 billion
of leveraged transactions and other private
equity and mezzanine investments, representing
investments in more than 450 media properties.
ABRY typically invests $20 million to $100
million of equity or $10 million to $50
million of mezzanine capital in a company,
and currently has approximately $1.7 billion
of total capital under management. |
ABS Capital Partners
Offices: Baltimore, Maryland; Boston,
Massachusetts & San Francisco, California
ABS has $1.5 billion under management and
ten investing partners. Over the past twelve
years, ABS Capital has invested in over
60 portfolio companies. The firm's investment
strategy focuses on companies in the health
care, technology, business services and
media & communications sectors. |
 |
|
|
|
|
 |